PT  - JOURNAL ARTICLE
ED  - ,
TI  - Correction: Phase I/II clinical trial of a helper peptide vaccine plus PD-1 blockade in PD-1 antibody-naïve and PD-1 antibody-experienced patients with melanoma (MEL64)
AID  - 10.1136/jitc-2022-005424corr1
DP  - 2022 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - e005424corr1
VI  - 10
IP  - 11
4099  - http://jitc.bmj.com/content/10/11/e005424corr1.short
4100  - http://jitc.bmj.com/content/10/11/e005424corr1.full
SO  - J Immunother Cancer2022 Nov 01; 10